Adherence to Quality Indicators and Survival in Patients With Breast Cancer

被引:62
作者
Cheng, Skye H. [1 ,2 ]
Wang, C. Jason [3 ,4 ,5 ,6 ,7 ]
Lin, Jin-Long [8 ]
Horng, Cheng-Fang [1 ]
Lu, Mei-Chun [1 ]
Asch, Steven M. [3 ,9 ]
Hilborne, Lee H. [3 ,10 ]
Liu, Mei-Ching [1 ]
Chen, Chii-Ming [1 ]
Huang, Andrew T. [1 ,2 ]
机构
[1] Koo Fdn Sun Yat Sen Canc Ctr, Taipei, Taiwan
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] RAND Hlth, Santa Monica, CA USA
[4] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Maternal & Child Hlth, Boston, MA 02118 USA
[6] Boston Univ, Sch Publ Hlth, Dept Pediat, Boston, MA 02118 USA
[7] Boston Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA 02118 USA
[8] Bur Natl Hlth Insurance, Taipei, Taiwan
[9] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med, Los Angeles, CA 90095 USA
[10] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
关键词
breast cancer; quality indicator; adherence; quality of care; OF-CARE; ADJUVANT CHEMOTHERAPY; HEALTH-CARE; RADIATION; THERAPY; RADIOTHERAPY; MASTECTOMY; PACLITAXEL; GUIDELINES; CHILDREN;
D O I
10.1097/MLR.0b013e3181893c4a
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: International initiatives increasingly advocate physician adherence to clinical protocols that have been shown to improve outcomes, yet the process-outcome relationship for adhering to breast cancer care protocol is unknown. Objective: This study explores whether 100% adherence to a set of quality indicators applied to individuals with breast cancer is associated with better survival. Research Design and Subjects: Ten quality indicators (4 diagnosis-related and 6 treatment-related indicators) were used to measure the quality of care in 1378 breast cancer patients treated from 1995 to 2001. Adherence to each indicator was based on the number of procedures performed divided by the number of patients eligible for that procedure. The main analysis of adherence was dichotomous (ie, 100% adherence vs. < 100% adherence). Measures: The outcome measures studied were 5-year overall survival and progression-free survival, calculated using the Kaplan-Meier method. The Cox's proportional hazard regression model was used for univariate and multivariate analyses. Results: Most patients received care that demonstrated good adherence to the quality indicators. Multivariate analysis revealed that 100% adherence to entire set of quality indicators was significantly associated with better overall survival [hazard ratio (HR): 0.46; 95% confidence interval (CI): 0.33-0.63] and progression-free survival (HR 0.51-1 95% CI, 0.39-0.67). One hundred percent adherence to treatment indicators alone was also associated with statistically significant improvements in overall and progress ion-free survivals. Conclusions: Our study strongly supports that 100% adherence to evidence supported quality-of-care indicators is associated with better Survival rates for breast cancer patients and should be a priority for practitioners.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 46 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]  
[Anonymous], 1985, JAMA-J AM MED ASSOC, V254, P3461
[3]  
[Anonymous], 2012, Cancer Trends Progress Report - 2011/2012 Update
[4]  
Asch SM., 2000, Quality of Care for Oncologic Conditions and HIV
[5]   Guidelines on endocrine therapy of breast cancer EUSOMA - Introduction [J].
Blamey, RW .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) :615-617
[6]  
BROOK RH, 1994, AHCPR PUB
[7]   EFFECT OF DELAY IN RADIATION IN THE COMBINED MODALITY TREATMENT OF BREAST-CANCER [J].
BUCHHOLZ, TA ;
AUSTINSEYMOUR, MM ;
MOE, RE ;
ELLIS, GK ;
LIVINGSTON, RB ;
PELTON, JG ;
GRIFFIN, TW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01) :23-35
[8]  
*BUR HLTH PROM, 2005, CANC REG ANN REP 200
[9]   Unique features of breast cancer in Taiwan [J].
Cheng, SH ;
Tsou, MH ;
Liu, MC ;
Jian, JJ ;
Cheng, JCH ;
Leu, SY ;
Hsieh, CY ;
Huang, AT .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (03) :213-223
[10]   Duration of adjuvant chemotherapy for breast cancer:: a joint analysis of two randomised trials investigating three versus six courses of CMF [J].
Colleoni, M ;
Litman, HJ ;
Castiglione-Gertsch, M ;
Sauerbrei, W ;
Gelber, RD ;
Bonetti, M ;
Coates, AS ;
Schumacher, M ;
Bastert, G ;
Rudenstam, CM ;
Schmoor, C ;
Lindtner, J ;
Collins, J ;
Thürlimann, B ;
Holmberg, SB ;
Crivellari, D ;
Beyerle, C ;
Neumann, RLA ;
Goldhirsch, A .
BRITISH JOURNAL OF CANCER, 2002, 86 (11) :1705-1714